Pharsight Monthly Summary
DECEMBER, 2025
Recent happenings in patent protected drugs.
spacer_11
At a Glance
84
drug patents lapsed
Photos
31
new drug patents introduced
Reviews
spacer_11
Companies who recently launched drugs
 
 
AAA USA INC
 
ACERUS
 
ARROWHEAD
 
ASTELLAS
 
ASTRAZENECA AB
 
AXSOME
 
AZURITY
 
EISAI INC
 
GLAXOSMITHKLINE
 
HARROW EYE
 
IMPAX
 
KK BCJ-94
 
MAYNE PHARMA
 
MERZ
 
NOVARTIS
 
UCB INC
 
 
spacer_11
Drugs not protected by their main patents
Drug Company
ABILIFY OTSUKA
ABILIFY ASIMTUFII OTSUKA
ABILIFY MAINTENA KIT OTSUKA PHARM CO LTD
ABILIFY MYCITE KIT OTSUKA
ADASUVE NOVA PNEUMA
ADDYI SPROUT PHARMS
ADLYXIN SANOFI-AVENTIS US
AGGRASTAT MEDICURE
ALDARA BAUSCH
ARCAPTA NEOHALER NOVARTIS
ARNUITY ELLIPTA GLAXOSMITHKLINE
AURYXIA KERYX BIOPHARMS
AXUMIN BLUE EARTH
BELVIQ EISAI INC
BREO ELLIPTA GLAXO GRP LTD
BRILINTA ASTRAZENECA
BYDUREON BCISE ASTRAZENECA AB
CLEVIPREX CHIESI
COMPLERA GILEAD SCIENCES INC
COPAXONE TEVA PHARMS USA
CRESEMBA ASTELLAS
DALIRESP ASTRAZENECA
DEXILANT TAKEDA PHARMS USA
DEXILANT SOLUTAB TAKEDA PHARMS USA
DIPRIVAN FRESENIUS KABI USA
DUAKLIR PRESSAIR COVIS
EDARBI AZURITY
EDARBYCLOR AZURITY
EDURANT JANSSEN PRODS
EDURANT PED JANSSEN PRODS
ELELYSO PFIZER
EMEND MSD MERCK CO
EPIVIR VIIV HLTHCARE
FERAHEME COVIS
FLONASE SENSIMIST ALLERGY RELIEF HALEON US HOLDINGS
GADAVIST BAYER HLTHCARE
GILENYA NOVARTIS
GLEEVEC NOVARTIS
GLUMETZA SANTARUS INC
INCIVEK VERTEX PHARMS
IQIRVO IPSEN
IRESSA ASTRAZENECA
JADENU SPRINKLE NOVARTIS
JENTADUETO BOEHRINGER INGELHEIM
JENTADUETO XR BOEHRINGER INGELHEIM
JEVTANA KIT SANOFI AVENTIS US
JUXTAPID CHIESI
LATUDA SUNOVION PHARMS INC
LEVEMIR FLEXTOUCH NOVO NORDISK INC
LIPTRUZET ORGANON
LUMASON BRACCO
LYMPHOSEEK KIT CARDINAL HEALTH 414
LYRICA CR UPJOHN
MACRILEN AETERNA ZENTARIS
MOVIPREP SALIX PHARMS
MYRBETRIQ GRANULES APGDI
NEXIUM 24HR ASTRAZENECA LP
NORDITROPIN FLEXPRO NOVO NORDISK INC
NOURIANZ KYOWA KIRIN
NOVOLOG FLEXTOUCH NOVO NORDISK INC
NOXAFIL MERCK SHARP DOHME
NUCYNTA COLLEGIUM PHARM INC
NUCYNTA ER COLLEGIUM PHARM INC
OFEV BOEHRINGER INGELHEIM
OMONTYS TAKEDA PHARMS USA
OMONTYS PRESERVATIVE FREE TAKEDA PHARMS USA
OPSUMIT ACTELION
OPSYNVI ACTELION
ORBACTIV MELINTA THERAP
OXYCONTIN PURDUE PHARMA LP
PEPAXTO ONCOPEPTIDES AB
PEXEVA SEBELA IRELAND LTD
PRADAXA BOEHRINGER INGELHEIM
PROLENSA BAUSCH AND LOMB
PROMACTA NOVARTIS
PROMACTA KIT NOVARTIS
RAPIVAB BIOCRYST
REYATAZ BRISTOL MYERS SQUIBB
SAXENDA NOVO
SELZENTRY VIIV HLTHCARE
SOLIQUA 100/33 SANOFI-AVENTIS US
SOMAVERT PHARMACIA
SPIRIVA RESPIMAT BOEHRINGER INGELHEIM
STENDRA VIVUS LLC
SYNRIBO TEVA PHARMS INTL
TARGINIQ PURDUE PHARMA LP
TORISEL PF PRISM CV
TRADJENTA BOEHRINGER INGELHEIM
TRILIPIX ABBVIE
TRUVADA GILEAD
TUDORZA PRESSAIR COVIS
UTIBRON NEOHALER NOVARTIS
VARITHENA PROVENSIS
VASCEPA AMARIN PHARMS
VELPHORO VIFOR FRESENIUS
VENLAFAXINE BESYLATE ALMATICA
VICTOZA NOVO NORDISK INC
VICTRELIS MERCK SHARP DOHME
VIIBRYD ABBVIE
VIZAMYL GE HEALTHCARE
VYLEESI (AUTOINJECTOR) COSETTE
VYONDYS 53 SAREPTA THERAPS INC
VYVANSE TAKEDA PHARMS USA
XARELTO JANSSEN PHARMS
XEGLYZE HATCHTECH
XELJANZ PFIZER
XELJANZ PF PRISM CV
XELJANZ XR PFIZER
XEPI LNHC
XOPENEX HFA LUPIN
XTORO FONSECA BIOSCIENCES
ZYVOX PFIZER
Drug patents lapsed
Drug Patent Patent expiry
AKLIEF 8227507 2025-12-21
AKLIEF 8470871 2025-12-21
BELVIQ 8697686 2025-12-20
BELVIQ 8980881 2025-12-20
BELVIQ XR 8697686 2025-12-20
BELVIQ XR 8980881 2025-12-20
BOSULIF 7417148 2025-12-11
BOSULIF 7919625 2025-12-11
BOSULIF 7417148 2025-12-11
BOSULIF 7919625 2025-12-11
BOSULIF 7417148 2025-12-11
BOSULIF 7919625 2025-12-11
BOSULIF 7417148 2025-12-11
BOSULIF 7919625 2025-12-11
BOSULIF 7417148 2025-12-11
BOSULIF 7919625 2025-12-11
BYDUREON 7456254*PED 2025-12-30
BYDUREON BCISE 7456254*PED 2025-12-30
BYDUREON PEN 7456254*PED 2025-12-30
COMPLERA 8841310 2025-12-09
FARXIGA 7456254*PED 2025-12-30
FARXIGA 7456254*PED 2025-12-30
JEVTANA KIT 7241907 2025-12-10
KLISYRI 8236799 2025-12-28
KLISYRI 8980890 2025-12-28
LATUDA RE45573*PED 2025-12-23
LATUDA RE45573*PED 2025-12-23
LATUDA RE45573*PED 2025-12-23
LATUDA RE45573*PED 2025-12-23
LATUDA RE45573*PED 2025-12-23
MEKINIST 8835443*PED 2025-12-10
MEKINIST 8835443*PED 2025-12-10
MEKINIST 8835443*PED 2025-12-10
MEKINIST 8835443*PED 2025-12-10
NESINA 8173663 2025-12-02
NESINA 8173663 2025-12-02
NESINA 8173663 2025-12-02
NEVANAC 8071648 2025-12-02
NEVANAC 8324281 2025-12-02
NUCYNTA 7994364*PED 2025-12-27
NUCYNTA 7994364*PED 2025-12-27
NUCYNTA 7994364*PED 2025-12-27
NUCYNTA 7994364*PED 2025-12-27
NUCYNTA ER 7994364*PED 2025-12-27
NUCYNTA ER 7994364*PED 2025-12-27
NUCYNTA ER 7994364*PED 2025-12-27
NUCYNTA ER 7994364*PED 2025-12-27
NUCYNTA ER 7994364*PED 2025-12-27
OPSUMIT 7094781 2025-12-05
OPSYNVI 7094781 2025-12-05
OPSYNVI 7094781 2025-12-05
ORACEA 8206740 2025-12-24
ORSERDU 8399520 2025-12-25
ORSERDU 8399520 2025-12-25
POMALYST 8198262*PED 2025-12-17
POMALYST 8198262*PED 2025-12-17
POMALYST 8198262*PED 2025-12-17
POMALYST 8198262*PED 2025-12-17
PONVORY 8273779 2025-12-17
PONVORY 8273779 2025-12-17
PONVORY 8273779 2025-12-17
PONVORY 8273779 2025-12-17
PONVORY 8273779 2025-12-17
PONVORY 8273779 2025-12-17
PONVORY 8273779 2025-12-17
PONVORY 8273779 2025-12-17
PONVORY 8273779 2025-12-17
PONVORY 8273779 2025-12-17
SIGNIFOR 8299209 2025-12-27
SIGNIFOR 8299209 2025-12-27
SIGNIFOR 8299209 2025-12-27
SPINRAZA 10266822 2025-12-05
SPINRAZA 8110560 2025-12-05
SUMAVEL DOSEPRO 8241243 2025-12-25
TAFINLAR 8835443*PED 2025-12-10
TAFINLAR 8835443*PED 2025-12-10
TAFINLAR 8835443*PED 2025-12-10
WINLEVI 8865690 2025-12-27
XELJANZ RE41783 2025-12-08
XELJANZ RE41783 2025-12-08
XELJANZ RE41783 2025-12-08
XELJANZ XR RE41783 2025-12-08
XELJANZ XR RE41783 2025-12-08
XHANCE 7975690 2025-12-29
Newly introduced Drug Patents
Drug Patent Patent expiry
BLUJEPA 10702521 2035-08-20
BLUJEPA 11229646 2035-08-20
CREXONT 12491164 2034-10-07
FARXIGA 12213988*PED 2041-10-01
FARXIGA 12409186*PED 2041-10-01
FARXIGA 12472194*PED 2040-01-18
INBRIJA 12458615 2033-10-21
KYGEVVI 10471087 2036-08-07
KYGEVVI 11649259 2040-08-19
LENVIMA 12508313 2030-10-04
LENVIMA 12508313*PED 2031-04-04
LUTATHERA 12168063*PED 2039-01-25
LUTATHERA 12415003*PED 2039-01-25
LUTATHERA 12491272 2038-07-25
LUTATHERA 12491272*PED 2039-01-25
NATESTO 11744838 2034-03-17
RADICAVA ORS 12478611 2041-11-12
REDEMPLO 10294474 2037-03-07
REDEMPLO 10597657 2038-09-10
REDEMPLO 11174481 2037-03-07
REDEMPLO 11214801 2038-09-10
REDEMPLO 12365899 2038-09-10
SYMBRAVO 12472256 2038-05-18
SYMBRAVO 12472257 2038-05-18
SYMBRAVO 12472258 2038-05-18
SYMBRAVO 12485176 2036-04-11
TWYNEO 12491163 2041-05-23
VEVYE 12496326 2036-09-29
VIJOICE 11433059 2037-02-17
XTANDI 12502357 2033-09-11
ZONISADE 12491179 2038-08-18
What's new on Pharsight!

Find the answers you need on Drugs.

Are you looking for accurate and reliable information on drugs and generics? Look no further! Our FAQ page is packed with answers to some of the most commonly asked questions about drugs. Visit and bookmark our FAQ page today!

Bonus - Don't see your question answered there? Contact us, and we'll be happy to help!

Check out FAQ page

Shoot first, and win big! Figure out the drugs that are about to enter the NCE-1 period to stay ahead of your generic launch strategy!

Want to be first-to-market with your generic drugs? Stay ahead of the game with our exclusive list of drugs facing patent challenges updated every month.

Check out NCE-1 period list

spacer_11

Our insights are consumed by 1000+ leading pharma companies

© 2025 GreyB Research